Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Johnson and Johnson

Generated: December 18, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

When do Edrophonium Chloride patents expire, and what generic alternatives are available?

Edrophonium Chloride is a drug marketed by Hospira and Watson Labs and is included in three NDAs.

The generic ingredient in EDROPHONIUM CHLORIDE is edrophonium chloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the edrophonium chloride profile page.
Drug patent expirations by year for EDROPHONIUM CHLORIDE

Medical Subject Heading (MeSH) Categories for EDROPHONIUM CHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
HospiraEDROPHONIUM CHLORIDEedrophonium chlorideINJECTABLE;INJECTION040131-001Feb 24, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson LabsEDROPHONIUM CHLORIDEedrophonium chlorideINJECTABLE;INJECTION040044-001Mar 20, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson LabsEDROPHONIUM CHLORIDE PRESERVATIVE FREEedrophonium chlorideINJECTABLE;INJECTION040043-001Mar 20, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
US Department of Justice
Johnson and Johnson
Queensland Health
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: